SUNPHARMA stock
SUNPHARMA is in a mixed news setup around Pharma; 61 recent stories are active but the saved quote move at +0.00% keeps the read balanced.
SUNPHARMA has built a mixed coverage cluster in the last 30 days. The strongest recurring theme is Pharma, while the current weighted impact score is +14 from 32 bullish, 21 bearish, and 8 neutral stories across 5 sources.
SUNPHARMA is last saved at ₹1,925 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is the latest financial report for SUNPHARMA. We don't have previous numbers to compare, so we can't say if things improved or worsened this quarter. This report simply records the company's current financial performance. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 10 hr ago · 2 min read
Economic Times · 2 days ago · 2 min read
Mint · 4 days ago · 2 min read
Economic Times · 4 days ago · 2 min read
Economic Times · 5 days ago · 2 min read
How SUNPHARMA stacks against related names in this news cluster
SUNPHARMA has appeared across 61 recent stories from 5 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
SUNPHARMA coverage is currently leaning bullish, with 32 bullish, 21 bearish, and 8 neutral analyzed stories in the recent window.
Recent SUNPHARMA coverage is clustering around Pharma and Pharmaceuticals. Related names showing up alongside SUNPHARMA include AUROPHARMA, LUPIN, CIPLA.
Use this page as a coverage hub for SUNPHARMA: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
19 recent mentions linked to SUNPHARMA
TopicPharmaceuticals17 recent mentions linked to SUNPHARMA
StockAUROPHARMARelated news cluster with 8 links
Latest storyNifty Falls on Global Cues; SUNPHARMA, NESTLEIND Gain, Adani StocksThe pharma sector often acts as a defensive play during broader market downturns, especially when gl
How retail crowds and channels are talking about SUNPHARMA right now — context for your own research, not a trade call.